Raymond James Financial’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.29B Buy
4,374,832
+55,069
+1% +$16.4M 0.4% 40
2025
Q4
$1.18B Buy
4,319,763
+222,890
+5% +$60.6M 0.37% 38
2025
Q3
$1.11B Sell
4,096,873
-4,796
-0.1% -$1.3M 0.36% 42
2025
Q2
$1.13B Sell
4,101,669
-12,322
-0.3% -$3.35M 0.39% 36
2025
Q1
$1.09B Buy
4,113,991
+363,130
+10% +$89.6M 0.41% 37
2024
Q4
$871M Buy
+3,750,861
New +$863M 0.32% 51

Other funds holding CME

Raymond James Financial's CME Position: Q1 2026 in Review

Raymond James Financial increased its CME Group (CME) stake by 1.3% in Q1 2026, buying an estimated $16.4M and bringing the position to 4,374,832 shares worth $1.29B. The position accounts for 0.4% of the portfolio, ranked #40.

Raymond James Financial first reported a position in CME in Q4 2024 and has held it in 6 quarters since. 1,793 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Raymond James Financial held 4,374,832 shares of CME Group worth $1.29B as of Q1 2026.
  • Raymond James Financial bought 55,069 CME Group shares in Q1 2026, an estimated $16.4M.
  • CME Group made up 0.4% of Raymond James Financial's portfolio in Q1 2026, its #40 holding.
  • Raymond James Financial first reported a position in CME Group in Q4 2024 and has held it in 6 quarters since.
  • 1,793 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.